Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 684 word(s) 684 2020-12-15 07:23:27

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Yin, N. Familial Mediterranean Fever. Encyclopedia. Available online: (accessed on 22 June 2024).
Yin N. Familial Mediterranean Fever. Encyclopedia. Available at: Accessed June 22, 2024.
Yin, Nicole. "Familial Mediterranean Fever" Encyclopedia, (accessed June 22, 2024).
Yin, N. (2020, December 25). Familial Mediterranean Fever. In Encyclopedia.
Yin, Nicole. "Familial Mediterranean Fever." Encyclopedia. Web. 25 December, 2020.
Familial Mediterranean Fever

Familial Mediterranean fever is an inherited condition characterized by recurrent episodes of painful inflammation in the abdomen, chest, or joints. These episodes are often accompanied by fever and sometimes a rash or headache. Occasionally inflammation may occur in other parts of the body, such as the heart; the membrane surrounding the brain and spinal cord; and in males, the testicles. In about half of affected individuals, attacks are preceded by mild signs and symptoms known as a prodrome. Prodromal symptoms include mildly uncomfortable sensations in the area that will later become inflamed, or more general feelings of discomfort.

genetic conditions

1. Introduction

The first episode of illness in familial Mediterranean fever usually occurs in childhood or the teenage years, but in some cases, the initial attack occurs much later in life. Typically, episodes last 12 to 72 hours and can vary in severity. The length of time between attacks is also variable and can range from days to years. During these periods, affected individuals usually have no signs or symptoms related to the condition. However, without treatment to help prevent attacks and complications, a buildup of protein deposits (amyloidosis) in the body's organs and tissues may occur, especially in the kidneys, which can lead to kidney failure.

2. Frequency

Familial Mediterranean fever primarily affects populations originating in the Mediterranean region, particularly people of Armenian, Arab, Turkish, or Jewish ancestry. The disorder affects 1 in 200 to 1,000 people in these populations. It is less common in other populations.

3. Causes

Mutations in the MEFV gene cause familial Mediterranean fever. The MEFV gene provides instructions for making a protein called pyrin (also known as marenostrin), which is found in white blood cells. This protein is involved in the immune system, helping to regulate the process of inflammation. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. When this process is complete, the body stops the inflammatory response to prevent damage to its own cells and tissues.

Mutations in the MEFV gene reduce the activity of the pyrin protein, which disrupts control of the inflammation process. An inappropriate or prolonged inflammatory response can result, leading to fever and pain in the abdomen, chest, or joints.

Normal variations in the SAA1 gene may modify the course of familial Mediterranean fever. Some evidence suggests that a particular version of the SAA1 gene (called the alpha variant) increases the risk of amyloidosis among people with familial Mediterranean fever.

4. Inheritance

Familial Mediterranean fever is almost always inherited in an autosomal recessive pattern, which means both copies of the MEFV gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

In rare cases, this condition appears to be inherited in an autosomal dominant pattern. An autosomal dominant inheritance pattern describes cases in which one copy of the altered gene in each cell is sufficient to cause the disorder. In autosomal dominant inheritance, affected individuals often inherit the mutation from one affected parent.

However, another mechanism is believed to account for some cases of familial Mediterranean fever that were originally thought to be inherited in an autosomal dominant pattern. A gene mutation that occurs frequently in a population may result in a disorder with autosomal recessive inheritance appearing in multiple generations in a family, a pattern that mimics autosomal dominant inheritance. If one parent has familial Mediterranean fever (with mutations in both copies of the MEFV gene in each cell) and the other parent is an unaffected carrier (with a mutation in one copy of the MEFV gene in each cell), it may appear as if the affected child inherited the disorder only from the affected parent. This appearance of autosomal dominant inheritance when the pattern is actually autosomal recessive is called pseudodominance.

5. Other Names for This Condition

  • benign paroxysmal peritonitis
  • familial paroxysmal polyserositis
  • FMF
  • MEF
  • recurrent polyserositis
  • Reimann periodic disease
  • Siegal-Cattan-Mamou disease
  • Wolff periodic disease


  1. Bakkaloglu A. Familial Mediterranean fever. Pediatr Nephrol. 2003Sep;18(9):853-9.
  2. Bhat A, Naguwa SM, Gershwin ME. Genetics and new treatment modalities forfamilial Mediterranean fever. Ann N Y Acad Sci. 2007 Sep;1110:201-8. Review.
  3. Booth DR, Gillmore JD, Lachmann HJ, Booth SE, Bybee A, Soytürk M, Akar S,Pepys MB, Tunca M, Hawkins PN. The genetic basis of autosomal dominant familialMediterranean fever. QJM. 2000 Apr;93(4):217-21.
  4. Eisenstein EM, Berkun Y, Ben-Chetrit E. Familial Mediterranean fever: acritical digest of the 2012-2013 literature. Clin Exp Rheumatol. 2013May-Jun;31(3 Suppl 77):103-7.
  5. Lidar M, Kedem R, Berkun Y, Langevitz P, Livneh A. Familial Mediterraneanfever in Ashkenazi Jews: the mild end of the clinical spectrum. J Rheumatol. 2010Feb;37(2):422-5. doi: 10.3899/jrheum.090401.
  6. Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular andmanagement advancements. Neth J Med. 2007 Oct;65(9):318-24.
  7. Mikula M, Buller A, Sun W, Strom CM. Prevalence of known mutations in thefamilial Mediterranean fever gene (MEFV) in various carrier screeningpopulations. Genet Med. 2008 May;10(5):349-52. doi: 10.1097/GIM.0b013e3181723cc8.
  8. Rabinovitch E, Harats D, Yaron P, Luvish T, Lidar M, Kedem R, Shaish A,Ben-Dov I, Livneh A. Familial Mediterranean fever gene and protection againstasthma. Ann Allergy Asthma Immunol. 2007 Dec;99(6):517-21. doi:10.1016/S1081-1206(10)60380-8.
  9. Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, Danon Y, Halpern GJ, Lifshitz Y, Shohat M. Higher than expected carrier rates for familialMediterranean fever in various Jewish ethnic groups. Eur J Hum Genet. 2000Apr;8(4):307-10.
  10. Yepiskoposyan L, Harutyunyan A. Population genetics of familial Mediterranean fever: a review. Eur J Hum Genet. 2007 Sep;15(9):911-6.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 495
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020
Video Production Service